| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001836929 |
| P356 | DOI | 10.1007/BF00046349 |
| P698 | PubMed publication ID | 9034598 |
| P2093 | author name string | J Zhang | |
| S J Russell | |||
| P2860 | cites work | Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. | Q45875930 |
| Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway. | Q52517615 | ||
| A genetic approach to idiotypic vaccination | Q62028860 | ||
| Cellular promoters incorporated into the adenovirus genome. Effect of viral DNA replication on endogenous and exogenous gene transcription | Q64379864 | ||
| Why did they die? | Q67966170 | ||
| The c-erb B-2 proto-oncogene in human pancreatic cancer | Q68536826 | ||
| Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice | Q69368112 | ||
| Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects | Q70030614 | ||
| Inducible expression of a foreign gene inserted into the human cytomegalovirus genome | Q70468560 | ||
| Foamy virus vectors | Q70792195 | ||
| Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene | Q71084079 | ||
| Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients | Q72656870 | ||
| Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters | Q24315645 | ||
| The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor | Q24328901 | ||
| A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family | Q24337205 | ||
| The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells | Q24564509 | ||
| The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes | Q24564711 | ||
| Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression | Q24599825 | ||
| Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector | Q24647777 | ||
| Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production | Q27485930 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1 | Q28268054 | ||
| HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase | Q28291170 | ||
| Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus | Q28576023 | ||
| Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone | Q33578778 | ||
| Integration of murine leukemia virus DNA depends on mitosis | Q34051046 | ||
| Evidence that retroviruses integrate into post-replication host DNA | Q34064403 | ||
| Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery | Q34066344 | ||
| Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector | Q34200458 | ||
| Strategy for achieving selective killing of carcinomas | Q34297324 | ||
| Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas | Q34297434 | ||
| Targeting of retroviral vectors for gene therapy | Q34365155 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| Endowing T cells with antibody specificity using chimeric T cell receptors | Q35595600 | ||
| Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter | Q35768314 | ||
| E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication | Q35800028 | ||
| Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes. | Q35829913 | ||
| Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer | Q35838311 | ||
| Retroviral retargeting by envelopes expressing an N-terminal binding domain. | Q35848344 | ||
| High-titer packaging cells producing recombinant retroviruses resistant to human serum | Q35851698 | ||
| Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant | Q41451279 | ||
| Identification of a T cell-specific transcriptional enhancer 3' of the human T cell receptor gamma locus | Q41482592 | ||
| Human immunodeficiency virus infection of cells arrested in the cell cycle | Q41531689 | ||
| Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector | Q41590056 | ||
| Gene Transfer in Human Lymphocytes Using a Vector Based on Adeno-Associated Virus | Q41627514 | ||
| Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses | Q41743762 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer | Q42373194 | ||
| In vitro and in vivo targeting of gene expression to melanoma cells | Q42510139 | ||
| A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection | Q42798292 | ||
| Protection of retroviral vector particles in human blood through complement inhibition | Q42828988 | ||
| Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer | Q42829604 | ||
| Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression | Q44434974 | ||
| Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. | Q45774793 | ||
| Critical involvement of human T cell leukaemia virus type I virions in mediating the viral mitogenic effect | Q45780916 | ||
| Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1 | Q45788447 | ||
| Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors | Q45845718 | ||
| Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant | Q45854779 | ||
| Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. | Q45866620 | ||
| Gene therapy for cancer using tumour-specific prodrug activation | Q45867184 | ||
| Addition of a short peptide ligand to the adenovirus fiber protein. | Q45875881 | ||
| Suppression of cellular proliferation by the papillomavirus E2 protein | Q35852233 | ||
| Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes | Q36156054 | ||
| Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway | Q36359927 | ||
| Transcriptional regulation of the T cell antigen receptor zeta subunit: identification of a tissue-restricted promoter | Q36363777 | ||
| Functional exchange of an oncoretrovirus and a lentivirus matrix protein | Q36622422 | ||
| Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors | Q36622965 | ||
| Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. | Q36634983 | ||
| Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. | Q36640292 | ||
| Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes | Q36649855 | ||
| Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. | Q36686256 | ||
| Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus | Q36697316 | ||
| Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer | Q36745744 | ||
| Human immunodeficiency virus pseudotypes with expanded cellular and species tropism | Q36806036 | ||
| Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent | Q36830482 | ||
| Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. | Q36866826 | ||
| Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression | Q36899070 | ||
| Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors | Q38138826 | ||
| Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. | Q38288275 | ||
| Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. | Q38362924 | ||
| Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses | Q38930916 | ||
| Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture | Q39160064 | ||
| Inactivation of lysis of oncornaviruses by human serum | Q39406513 | ||
| The biological modification of tumor cells as a means of inducing their regression: an overview | Q39730361 | ||
| Human serum lyses RNA tumour viruses | Q39953990 | ||
| Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. | Q40042967 | ||
| Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. | Q40045880 | ||
| Cell-type-specific control elements of the lymphotropic papovavirus enhancer | Q40108480 | ||
| Construction of retroviral vectors for targeted delivery and expression of therapeutic genes | Q40368888 | ||
| Non-viral approaches to gene therapy | Q40401187 | ||
| Retroviral vectors displaying functional antibody fragments | Q40405683 | ||
| Transfer of genes to humans: early lessons and obstacles to success | Q40418899 | ||
| Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway | Q40428991 | ||
| The use of DNA viruses as vectors for gene therapy | Q40429002 | ||
| Replicating vectors for gene therapy of cancer: risks, limitations and prospects | Q40470684 | ||
| Replicating vectors for cancer therapy: a question of strategy. | Q40498554 | ||
| Retroviruses as vectors | Q40537182 | ||
| Adenovirus and adeno-associated virus mediated gene transfer | Q40537236 | ||
| Herpes virus-based vectors | Q40537241 | ||
| Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum | Q41192433 | ||
| Targeting of retroviral vectors through protease-substrate interactions. | Q41208742 | ||
| Alphaviruses as vectors for gene delivery | Q41233828 | ||
| Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. | Q41240724 | ||
| Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter | Q41266120 | ||
| Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy | Q41331857 | ||
| An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. | Q41396968 | ||
| Tissue-specific targeting of retroviral vectors through ligand-receptor interactions | Q41428152 | ||
| Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. | Q41443981 | ||
| P433 | issue | 3 | |
| P921 | main subject | gene therapy | Q213901 |
| cancer gene therapy | Q124350675 | ||
| P304 | page(s) | 385-401 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
| P1476 | title | Vectors for cancer gene therapy | |
| P478 | volume | 15 |
| Q43992111 | Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5. |
| Q83011609 | Gene doping: Olympic genes for Olympic dreams |
| Q34452694 | Gene transfer to induce angiogenesis in myocardial and limb ischaemia |
| Q45747136 | Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases |
| Q36379360 | Targeting vascular endothelial growth factor in angina therapy |
| Q47978690 | The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies |
| Q36596455 | The future of therapeutic myocardial angiogenesis |
| Q34464125 | Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted |
| Q40921899 | Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases. |
Search more.